Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer
Shu Li, Xiaofeng Li, Jianyi Ding, Lingfei Han, Xiaoqing GuoShanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of ChinaBackground: Ovarian cancer is a leading cause of death in gynecologic malignancies. The high...
Main Authors: | Li S, Li X, Ding J, Han L, Guo X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-04-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/anti-tumor-efficacy-of-folate-modified-plga-based-nanoparticles-for-th-peer-reviewed-article-DDDT |
Similar Items
-
Docetaxel delivery using folate-targeted liposomes: in vitro and in vivo studies
by: Roghayyeh Vakili-Ghartavol, et al.
Published: (2020-04-01) -
In vitro anticancer activity of folate-modified docetaxel-loaded PLGA nanoparticles against drug-sensitive and multidrug-resistant cancer cells
by: Yuri I. Poltavets, et al.
Published: (2019-05-01) -
Synthesis, characterization of catechin-loaded folate-conjugated chitosan nanoparticles and their anti-proliferative effect
by: Buyun Liu, et al.
Published: (2018-01-01) -
Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy
by: Zeng Xiaowei, et al.
Published: (2011-01-01) -
Synthesis and Characterizations of Folate-Conjugated PLGA-PEG Nanoparticles Loaded with Dual Agents
by: Yüksel Öğünç, et al.
Published: (2017-11-01)